Skip to main navigation Skip to search Skip to main content

Hyaluronic Acid-Bilirubin Nanoparticles as a Tumor Microenvironment Reactive Oxygen Species-Responsive Nanomedicine for Targeted Cancer Therapy

Press/Media

Period27 May 2024

Media coverage

1

Media coverage